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Abstract
Background: Compared to others, dialysis patients who are socioeconomically disadvantaged or Black are less likely to
receive education about deceased donor kidney transplant (DDKT) and living donor kidney transplant (LDKT) before they
reach transplant centers, often due to limited availability of transplant education within dialysis centers. Since these
patients are often less knowledgeable or ready to pursue transplant, educational content must be simplified, made
culturally sensitive, and presented gradually across multiple sessions to increase learning and honor where they are in
their decision-making about transplant. The Explore Transplant at Home (ETH) program was developed to help patients
learn more about DDKT and LDKT at home, with and without telephone conversations with an educator.
Methods and Study Design: In this randomized controlled trial (RCT), 540 low-income Black and White dialysis patients
with household incomes at or below 250 % of the federal poverty line, some of whom receive financial assistance from
the Missouri Kidney Program, will be randomly assigned to one of three education conditions: (1) standard-of-care
transplant education provided by the dialysis center, (2) patient-guided ETH (ETH-PG), and (3) health educator-guided
ETH (ETH-EG). Patients in the standard-of-care condition will only receive education provided in their dialysis centers.
Those in the two ETH conditions will receive four video and print modules delivered over an 8 month period by mail,
with the option of receiving supplementary text messages weekly. In addition, patients in the ETH-EG condition will
participate in multiple telephonic educational sessions with a health educator. Changes in transplant knowledge,
decisional balance, self-efficacy, and informed decision making will be captured with surveys administered before and
after the ETH education.
Discussion: At the conclusion of this RCT, we will have determined whether an education program administered to
socioeconomically disadvantaged dialysis patients, over several months directly in their homes, can help more
individuals learn about the options of DDKT and LDKT. We also will be able to examine the efficacy of different
educational delivery approaches to further understand whether the addition of a telephone educator is necessary for
increasing transplant knowledge.
Trial Registration: ClinicalTrials.gov, NCT02268682
Keywords: Kidney transplantation, Living donor, Racial disparities, African-Americans, Patient education, Health
knowledge/attitudes, Transtheoretical model of behavioral change, Stages of Change
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Background
In the United States there are approximately 637,000
patients with end-stage renal disease (ESRD) or kidney
failure [1]. There are two options for ESRD patients to
sustain life: dialysis or a kidney transplant from a
deceased or living donor [1–4]. Kidney transplantation,
especially living donor kidney transplant (LDKT), offers
ESRD patients 6 to 16 additional years of life and im-
proved quality-of-life compared to remaining on dialysis
[1–3]. However, the majority of ESRD patients–450,000
as of 2013– still remain on dialysis. Although dialysis is
life-saving, it only replaces 10-15 % of normal kidney
function and can lead to cardiovascular disease, infec-
tion, and other complications [5, 6]. Additionally, the
chance of a dialysis patient being alive after 5 years with-
out a transplant is only 40 % [7]. Acknowledging its bene-
fits over dialysis, the Centers for Medicare and Medicaid
Services (CMS) has required that all dialysis patients re-
ceive transplant education and be informed of their option
for transplant within 45 days of initiating dialysis.
In general ESRD patients who are Black and of lower
socioeconomic status (SES) are significantly less likely to
receive transplant education, pursue transplant evalu-
ation, and receive deceased donor kidney transplants
(DDKTs) and LDKTs [8, 9]. In fact, patients with kidney
disease from low-SES neighborhoods experience higher
mortality rates [10]. These patients may be more likely
to have particular concerns about the costs of transplant
medication [11], loss of disability benefits if they should
receive a transplant [12], and limited access to adequate
transportation to transplant appointments [13, 14].
Many low-SES patients may receive treatment at dialy-
sis facilities with systemic barriers, including limited
staff availability to provide education about transplant
[15–17] or limited access to transplant education ma-
terials [18]. Without information about the risks and
benefits of DDKT and LDKT, dialysis patients who do
not present at a transplant center are often unable to
make informed decisions about how best to treat their
kidney disease [19, 20].
In light of these barriers, a 2014 American Society of
Transplantation Consensus Conference recommended
multiple ways to improve educational outreach for ESRD
patients who have not yet presented at a transplant center
[21]. These recommendations included repeating educa-
tion multiple times and in settings prior to the transplant
center, providing more culturally competent education at
appropriate literacy levels, and using technology more ef-
fectively as an educational strategy. These approaches re-
flect a more general need to provide transplant education
both consistently and gradually over time for patients who
know less about it. Patients with significant barriers to
learning about transplant also may benefit from support
from a health educator, peer mentor, or social worker [22],
including repeated discussions and more opportunities to
ask questions about their transplant concerns.
Given the pressures on dialysis providers’ time [16]
health insurance companies have incorporated the use
of case managers or health educators within their orga-
nizations to distribute health information to patients via
mail or over the telephone [23]. Some approaches that
have been used to reach patients in clinical settings out-
side of dialysis centers involve mailing videos and print
educational content at multiple time points to reach pa-
tients and their support networks when they are home
[24], sending regular text messages to increase health
knowledge and promote healthy behaviors [25, 26], and
reinforcing educational content with a phone health
educator [23]. These approaches have been shown to be
effective in identifying patients with chronic illness early
in the course of disease progression and intervening to
increase knowledge of the best treatment options avail-
able, bridge the gaps in access to care, facilitate effective
communication between the patient and providers, ad-
vocate on behalf of the patient, and plan for successful
treatment outcomes in a high quality and cost-effective
manner [27–29].
Applying these educational strategies to transplant
education for the first time, we describe the protocol of
a randomized control trial (RCT) with low-SES, Black
and White dialysis patients comparing the efficacy of
two versions of the Explore Transplant at Home (ETH)
educational program with standard education being
provided within dialysis centers. The three education
conditions include: (1) standard-of- care education pro-
vided within dialysis centers; (2) a video-guided four-
part ETH program delivered via mail, plus optional
texts [ETH Patient-Guided (PG)]; and (3) a video-
guided four-part ETH program with discussion facili-
tated by a transplant educator via telephone [ETH
Educator-Guided (EG)]. We will compare whether
these three educational approaches improve Black and
White patients’ transplant knowledge, self-efficacy, and
informed decision-making. We will also explore which
DDKT and LDKT action steps patients commonly take
during an 8 month period.
Study Design and Methods
Foundations of ETH
There is general consensus that interventions grounded in
the best practices of behavioral change theories are more
effective than those not based in theory [30]. Noting that
many dialysis patients, especially racial minorities, are in
early stages of decision-making to pursue transplant [8],
there is critical need for an intervention that can meet pa-
tients where they are in this process and gradually in-
crease knowledge, leading them towards making informed
transplant choices. Dr. Waterman and her team previously
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designed and tested the Explore Transplant (ET) program
[19], a program grounded in the Transtheoretical Model
of Behavior Change (TTM) [31]. The TTM holds that
not all patients are ready to begin taking actions toward
health behavior change, and that patients’ decision-
making is impacted by their level of motivation, their
weighing of the Pros and Cons, and their self-efficacy
[31]. It has been successfully used to understand the
decision-making of patients considering whether to en-
gage in over 50 health behaviors [32–37], including de-
cision making about organ donation [38, 39]. Through a
group RCT, ET delivered face-to-face with patients
while they were undergoing dialysis by transplant educa-
tors was shown to increase patients’ knowledge, informed
decision-making, and pursuit of transplant [19]. As a result,
the Explore Transplant program won the 2009 National
Association of Transplant Professionals (NATCO) Quality
of Care Award.
Design and Advantages of Explore Transplant at Home
The original ET trial included four video and print
educational modules: Exploring Transplant, Kidney
Recipients’ Transplant Experiences, Living Donors'
Donation Experiences, and Deciding What to Do.
These modules were reviewed in person while the pa-
tients were undergoing dialysis within a one month
period. Recognizing the significant barriers that
disadvantaged dialysis patients face in pursuing trans-
plant, the ETH modules were redesigned to be deliv-
ered by mail to patients’ homes, with content delivered
more gradually, over an 8 month period, and in smaller
educational increments using supplementary texts,
postcards and, in one condition, telephone support from
an educator (Table 1). Both ET and ETH were developed
to encourage informed decision-making through a com-
prehensive explanation of the benefits and risks of dialysis,
DDKTand LDKT.
A Medical Advisory Board including social workers,
case managers, nephrologists, kidney patients, and ex-
perts in health education reviewed and approved all
components of the ETH educational intervention to en-
sure its cultural sensitivity and that the needs of low-
income and low health literacy groups were addressed.
Missouri Kidney Program
This study features a partnership between Dr. Waterman’s
transplant research team and the Missouri Kidney Pro-
gram (MoKP) [40]. Established in 1968 to serve and edu-
cate Missouri’s citizens with chronic kidney disease
(CKD), MoKP subsidizes the costs of dialysis and trans-
plant medication for low-income ESRD patients in Mis-
souri, effectively operating as an insurance company
would with respect to their 1,200 patient member group.
MoKP also has strong, statewide partnerships with over
Table 1 Explore Transplant at Home mailed intervention materials
Module Brochures Fact Sheets Postcards Videos
1 Explore Transplant: A Guide for
Family and Friends
Transplant or Dialysis Fact Sheet Your Exploration of Kidney
Transplant Begins at Home
Exploring Transplant
Why People Donate Their
Kidneys
Deceased or Living Donation Fact
Sheet
Explore Transplant with Your
Friends and Family
Why Kidney Patients Get
Transplants
Learn How Life Can Improve After
Transplant
2 – Recipient Evaluation, Surgery and
Recovery Fact Sheet




Possible Risks to Kidney Recipients
Fact Sheet
Compare the Risks and Benefits of
Transplants
Learn What Transplant Evaluation is
Like
3 – Living Donor Evaluation, Surgery and
Recovery Fact Sheet




Possible Risks to Living Donors Fact
Sheet
Learn Why People Want to Be
Living Donors
Compare the Risks and Benefits of
Living Donation
4 Deciding What to Do Kidney Disease Resources Fact Sheet Weigh the Pros and Cons of All
Your Options
Deciding What to Do
Missouri Transplant Centers Fact
Sheet
Consider Living Donation
Plan Your Next Steps
Totals 4 8 12 4
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160 dialysis centers across the state of Missouri (Fig. 1)
and fosters the exchange of medical, technical and admin-
istrative information among programs and professionals
who treat patients in these dialysis centers.
ETH Educational Components
Printed Materials
Many of the printed materials, including brochures and
factsheets, used as part of the ETH education program are
part of the original ET Program [19]. Every 8 weeks, within
the educational intervention period, patients in the ETH-
PG and ETH-EG intervention conditions will receive four
educational print and video modules by mail. Transplant
education postcards will also be mailed to patients every
two weeks following the mailing of each of the four mod-
ules, for a total of 12 postcards over the course of 8
months.
Videos
As part of their mailings, patients will receive four ET
DVD videos, averaging 20 minutes in length, to review
at home with people who help them make important
health decisions. If patients indicate that they do not
have a DVD player at home, one will be provided to
them as part of the trial. The videos include the stories
of 20 transplant recipients and living donors, and discuss
the questions and fears they had before getting a trans-
plant and why they became motivated to pursue trans-
plant. The health professionals in the videos provide
answers to common questions, including specifics about
transplant evaluation, surgery and recovery processes in-
volved with being a transplant recipient or a living
donor. All videos are closed-captioned for the hearing
impaired.
Text Messaging
Text messaging has become a popular form of commu-
nication [41] and a common way to receive updates and
important information quickly and conveniently [42].
Healthcare providers are now utilizing these short mes-
sages to deliver reminders to patients about appoint-
ments, prescription medications, and health education
[43, 44]. In the United States, 89 % of households have
access to a cell phone [45]. In 2011, 73 % of those who
owned cell phones used them to send and receive text
messages [46]. Thus, to increase the ways we can reach
Fig. 1 Intervention region: Missouri dialysis centers
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patients with educational messages, the ETH program
has incorporated the use of text messages that contain
recommendations, quiz questions, and educational facts
that complement the printed materials and videos dur-
ing each module. (Table 2). Patients in both ETH inter-
vention conditions will have the option of enrolling in
an educational text messaging service designed to sup-
plement the ETH education they are receiving in the
mail. Patients in the ETH-PG and ETH-EG conditions will
receive a minimum of 67 messages. Those who respond to
interactive messages, such as quiz questions, could receive
up to 80 messages over the intervention period. Patients
who opt into the text messaging are provided $10 remu-
neration to cover the cost of standard text messaging rates.
Text messaging services are provided through Songwhale
LLC, [47] an institutional review board approved partner.
Transplant Educator
Patient support programs using health educators are in-
creasingly being offered under health insurance plans
[23] with staple components including patient assess-
ment planning, facilitation, and advocacy [29, 48].
Though this intervention was not able to provide a
comprehensive case management program, ETH has in-
corporated key tenets from case management models
and created a telephone transplant educator whose goal
is to guide patients through ETH to increase knowledge
and informed decision-making (ETH-EG condition
only). During a series of four calls, each lasting approxi-
mately 20 minutes, which will occur after each ETH
module is mailed, the educator and patient will review
the educational materials and discuss the risks and ben-
efits of transplantation. The educator will also provide
support by addressing patient concerns, problem-
solving, and practicing empathetic listening. The trans-
plant educator who delivers this intervention is a neph-
rology social worker who has had over 20 years of
experience working with CKD patients. The educator
has also received extensive training in the TTM and on
how to administer ETH.
Control Condition: Standard-of-Care
Patients randomized to the standard-of-care condition
will not receive any educational materials from our pro-
gram and will only participate in the survey portion of
the investigation. The study team will conduct a phone
survey to assess the actual educational practices occur-
ring within each dialysis center by interviewing the dialy-
sis providers who deliver transplant education. Research
has shown that the most common educational practices
in dialysis centers are recommending that patients learn
more or be evaluated for transplant referring patients to
an education program at a transplant center or kidney
organization, and providing them with brochures one
time [18]. Dialysis providers will be asked to continue
their current practices throughout the study period with-
out change. While Control patients will be free to ask
additional questions or solicit more information from
their dialysis educators at any point during the study
period, no additional educational interventions will be
delivered.
RCT Overview
This RCT has three conditions with equal allocation of
patients to each condition: (1) the control condition or
standard-of-care; (2) the ETH Patient-Guided (ETH-PG)
condition; and (3) the ETH Educator-Guided (ETH-EG)
condition (Fig. 2). All enrolled patients will complete a
baseline survey and a follow-up survey, 8 to 10 months
post-baseline. We will recruit 540 patients at the start of
the 8 month educational intervention period to complete
the baseline survey, with 180 patients in each condition.
After attrition, 150 patients in each condition (n = 450
total) are expected to complete the follow-up survey.
Patient Recruitment Eligibility, and Retention
The sample for our study will be drawn from the MoKP
patient roster plus additional patients from Missouri dia-
lysis centers. To enroll in the RCT each subject must:
(1) be 18–74 years of age, (2) self-identify as Black or
White race, (3) currently be on dialysis, (4) have a
household income at or below 250 % of the federal pov-
erty level, and (5) be able to speak and read in English.
Participants who meet any of the following exclusion cri-
teria are not enrolled: (1) has a visual and/or hearing im-
pairment that would preclude him/her from watching
and reading educational study materials, (2) has had a
previous kidney transplant, and/or (3) has previously
been told that they are not a candidate for transplant.
Those who are transplant-eligible will be contacted dir-
ectly by phone and via mailed letters, inviting them to par-
ticipate in our trial. Additionally, Kilgore’s Pharmacy,




Recommendation What does your family think about living donation as an option for you? Ask them! They know you the best and their opinions
might help you decide.
Quiz Can living donors who donate a kidney still have kids afterwards? Know the answer? Text back YES or NO.
Fact Did you know? Nationally, most patients wait, on average, 4 years for a kidney from the deceased donor waiting list.
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contracted by the University of Missouri Health System to
support patients who receive medication assistance through
MoKP, will insert flyers advertising the ETH research study
into patients’ prescription medication refills. After being in-
formed of the risks and benefits of the trial, patients will be
asked to give verbal informed consent to participate. If a
patient agrees to participate, he or she will be random-
ized to one of the three educational conditions using an
unrestricted (simple) random allocation sequence im-
plemented within the trial’s data capture software, after
they complete the baseline survey. The randomization
sequence was created by a data manager using a ran-
dom sequence generator, is stored in an encrypted
spreadsheet, and is not accessible by the principal
investigator. This protocol has been approved by the
University of California, Institutional Review Board
(#14-000802), the University of Missouri, Columbia
Institutional Review Board (#00048966), and is regis-
tered at ClinicalTrials.gov (#NCT02268682).
Survey Timepoints
Baseline Survey
Patients will complete a short phone screening (5 min.) to
assess whether they meet the eligibility criteria and if so,
are invited to participate, review the informed consent
sheet with a surveyor, and then complete a 45-minute
baseline survey. The survey assesses demographic, clinical
and cultural factors, socioeconomic transplant derailers,
baseline level of transplant knowledge, decisional balance,
self-efficacy, and any steps they may have taken to learn
about staying on dialysis, DDKT or LDKT. Patients will
receive $25 for completing the baseline survey.
Follow-up Survey
After the intervention period (approximately 8–10
months post-baseline) a 35-minute follow-up survey
will be completed over the phone to assess changes in
patients’ level of transplant knowledge, decisional bal-
ance, self-efficacy, informed decision-making, deci-
sional conflict, and any steps they may have taken to
learn about staying on dialysis, DDKT, or LDKT. They
will also complete a process evaluation about the
helpfulness of the ETH program. Patients who are
deemed ineligible for transplant or receive a trans-
plant during the interim period between the baseline
and follow-up surveys will be given only an abbrevi-
ated set of questions during the follow-up survey that
excludes any questions about their pursuit of trans-




Our primary outcome measure is level of DDKT and
LDKT knowledge. Patients will be asked 17 true/false
Fig. 2 Explore Transplant at Home study design
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and 8 multiple choice questions about the basic facts,
advantages, risks and outcomes of DDKT and LDKT to
assess knowledge levels (e.g., “Transplant recipients are
at risk of developing high blood pressure and high chol-
esterol,” “The transplant team will let a living donor
back out from donating on the day of the surgery”).
Informed Decision Making
Informed Decision-Making will be assessed in two ways.
First, patients will be asked three questions: “I have all
the facts I need to make an informed decision about
whether to pursue DDKT/LKDT/remain on dialysis”
(agree/disagree). Each of these questions will be treated
as an individual item and analyzed separately. We also
will administer the decisional conflict scale [49] to assess
factors contributing to patients’ uncertainty in making
health-related decisions, and patients’ assessment of
their perceived effective decision-making.
Small Steps toward DDKT and LDKT
Several action steps toward pursuit of both DDKT and
LDKT will be assessed using validated measures (e.g., “Do
you plan to call the transplant center to begin evaluation,”
“Do you plan to share your interest in living donation with
your family and friends?”) [50, 51], each of which the pa-
tient will report as having “already done,” “planning to
do,” or “don’t plan to do.”
Decisional Balance and Self-Efficacy
Validated Decisional Balance measures will assess patients’
perceived importance of the possible positive and negative
outcomes of LDKT and DDKT. Patients will be given the
prompt “How important is this statement to your decision
about transplant?” and then be asked to respond to 24
positive and negative statements (e.g., “I would not have
to be on dialysis,” “I would feel guilty having someone do-
nate to me”). Patients will be prompted to respond on a 5-
point Likert-type scale (1 = "Not important" through 5
= "Extremely important") [50, 51]. A Self-Efficacy scale
measures how confident an individual is in their ability to
pursue transplant if they encounter challenges along the
way with 14 questions. Patients are asked, “How confident
are you that you could get a transplant even if…,” followed
by a potential challenge, “You didn’t have your own trans-
portation to get to the transplant center?” Patients re-
sponses will range from (1) = " Not at all confident" to
(5) = " Completely confident" [50, 51].
Predictors and Covariates
Demographics Clinical and Cultural Factors
Demographic clinical, and cultural characteristics will be
assessed including age, sex, race/ethnicity, whether or not
a patient is on dialysis and what type (i.e., hemodialysis or
peritoneal), and patient comorbidities (e.g., polycystic kid-
ney disease). Additionally, a patient’s health-related quality
of life will be measured with the use of the Health Related
Quality of Life-4 (HRQOL-4) scale [52] and medical mis-
trust will be measured using the Medical Mistrust Index, a
validated scale that assesses how much patients trust
health care organizations (e.g., “When healthcare organi-
zations make mistakes they usually cover it up”) [53, 54].
Socioeconomic Transplant Derailers
We will also assess potential SES derailers that may in-
fluence patients’ experience with transplant evaluation
including level of education, employment status (full
time, part time, disability, other financial assistance pro-
grams, no employment), and the quality of health insur-
ance they have (private, government, multiple sources,
no insurance). Additional SES derailers assessed include
feelings of safety in their neighborhood, family obliga-
tions, income vulnerability [55], and access to transpor-
tation [56]. We will also measure patients' access to
multiple technologies and resources, such as having a
computer or cell phone, access to the internet, and a
DVD player.
Prior Transplant Education
As one of the primary outcome measures is transplant
knowledge, patients’ level of prior LDKT and DDKT
education will also be evaluated. Patients will be asked a
series of four Yes/No questions about their past behav-
iors (e.g., “Have you read brochures about transplants?”),
and if a patient positively endorses a statement, they will
be asked how many hours they have dedicated to each
educational activity.
Health Literacy
Patients will respond to two items: “How often do you
have someone (like a family member friend, hospital/
clinic worker or caregiver) help you read hospital mate-
rials?” and “How confident are you filling out forms by
yourself?” [57].
Evaluation and Process Measures
In the follow-up survey, patients will be asked about the
helpfulness of the ETH resources. Patients will also be
asked whether they agree with 7 statements relating to
how helpful they viewed the materials provided to them
(e.g., “The materials were easy to understand,” “The mate-
rials were overwhelming”) and the educator conversations
(e.g., “The Explore Transplant Educator was helpful”,
“The Explore Transplant Educator listened to what I had
to say”).
Waterman et al. BMC Nephrology  (2015) 16:150 Page 7 of 11
Data Management and Statistical Considerations
Data Management
To ensure participant confidentiality and privacy all data
will be stored in university-maintained, secured servers.
All study data will be captured in electronic databases
within the Research Electronic Data Capture (REDCap)
system [58]. Study personnel can check on patients’ re-
cords by examining their data entry form or through re-
ports generated in REDCap. The records of patients who
refuse to participate or are never successfully recruited
into the study will be retained in the REDCap registra-
tion database and de-identified at the end of the study
so that patterns in recruitment can be analyzed and
reported.
Power and Sample Size
Power analyses were based on changes in transplant
knowledge, our primary study outcome. The study de-
sign and analyses were treated as a test of the differ-
ences in mean knowledge score change between patients in
the ETH-PG, ETH-EG, and Control conditions, 8–10
months post-baseline. Power calculations were based on
the number of dialysis centers per condition, the number
of individuals per dialysis center, the expected intra-class
correlation, and the estimated variability of the outcome
variable [59]. Based on the original ET trial [19], we esti-
mated that a mean knowledge change score of 2.0 points
would be needed to detect a significant difference between
patients receiving standard-of-care, ETH-PG, and ETH-EG.
It was assumed that patients coming from the same dialysis
centers would have correlated knowledge scores. Since we
are examining 3 conditions, a Bonferroni correction was
required to adjust the Type 1 α for comparison of 3 group
means (0.05/3 = 0.017). Based on these assumptions, we
calculated that a design of 150 patients per condition, 450
patients total, will be required to find a mean change of 2.0
points in knowledge between groups at 90 % power.
Expecting an approximately 20 % attrition rate over time,
we are oversampling (180 patients per condition) to ensure
that we have sufficient power to be able to assess our pri-
mary endpoint at the completion of the study period.
Statistical Analyses
Where feasible and appropriate, multiple imputation will
be used to account for missing data [60]. Multilevel ran-
dom effects models (MRMs) will also be used to account
for correlated data (dialysis center clustering and serial
measurement). We will compare the characteristics of
patients who refuse to join the study or are never suc-
cessfully contacted to those who do not, as well as pa-
tients who drop-out to those who do not, to determine
if the patient selection procedure has biased the sample.
We will compare the difference in mean knowledge
change, change in self-efficacy, and change in decisional
balance (baseline to follow-up survey) of participants in
the 3 study arms using MRMs with normal outcome dis-
tributions. A MRM with a normal outcome distribution
will also be used to test for mean differences in the Deci-
sional Conflict Scale at 8 months post-baseline, and
Rao-Scott χ2 tests adjusting for dialysis center clustering
will be performed to test for differences in patients’ an-
swers to the informed decision-making items on the
follow-up survey: “I have all the facts I need to make an
informed decision about whether to stay on dialysis/pur-
sue DDKT/pursue LDKT” (agree/disagree). Rao-Scott χ2
tests will also be used to test differences in the propor-
tion of patients in each condition who took each small
step toward transplant (e.g., “Do you plan to share your
interest in living donation with your family and
friends?”), operationalized as the number who had not
taken each step at baseline but had at follow-up.
The heterogeneity of treatment effect will be tested
using interactions between the educational condition pa-
tients are assigned to and their demographic, psycho-
social, and clinical characteristics (e.g., race, level of SES
vulnerability, medical mistrust, health literacy), examin-
ing differences in changes in these groups' transplant
knowledge, decisional balance, self-efficacy, small steps
toward transplant, and informed decision-making using
MRMs. These models will determine whether the ETH
educational conditions are more or less effective for pa-
tients who: (1) have different SES barriers, (2) different
levels of health literacy and medical mistrust, and (3) are
Black or White. Finally, we will explore the impact of
the text messages by comparing all study outcomes be-
tween patients who did and did not enroll in the texting
program, stratified by whether the patient was random-
ized to the ETH-EG or ETH-PG condition, using MRMs.
Discussion
Kidney transplantation has clear survival and quality-
of-life benefits for patients; however, patients within
low-income and minority populations continue to have
limited access to the information they need to make an
informed decision about their CKD treatment options.
With the majority of dialysis patients dying within
5 years of starting dialysis [61], the importance of these
patients receiving comprehensive education prior to their
presentation at a transplant center about their other treat-
ment options–DDKT and LDKT–cannot be understated.
Since these patients are often less knowledgeable or ready
to pursue transplant, transplant educational content must
be simplified and made more culturally sensitive to honor
patients where they are in their decision-making process
about transplant.
Two recent transplant education interventions using
print education, videos, and educators have been imple-
mented with kidney patients prior to presenting to a
Waterman et al. BMC Nephrology  (2015) 16:150 Page 8 of 11
transplant center in an effort to reduce disparities in
pursuit or receipt of transplant [22, 62]. Compared to
patients receiving usual transplant education in dialysis
centers, a patient navigator intervention where previous
kidney transplant recipients led dialysis patients through
taking different transplant steps during a 2 year period
(e.g., increasing interest in transplant, getting on the
transplant wait-list, receiving a transplant) significantly
increased the number of steps patients actually took,
and was significantly associated with a higher likelihood
of wait-listing. A second trial examined the impact of an
educational intervention on transplant pursuit for CKD
3–5 patients recruited from community nephrology
practices [22]. Compared to standard-of-care education,
patients who received additional print and video educa-
tion with support from a social worker were more likely
to have discussions about transplant and take other
LDKT steps (e.g., identify potential living donors). Also,
the patients who only received educational materials
were more likely to begin and complete transplant evalu-
ation than the other two groups [22].
These studies show support for outreach-based,
culturally-compentent educational approaches to be
studied and further expanded in the ETH RCT described
here. However, neither of these studies examined
whether their respective interventions were effective
when targeted toward low-SES patients. Since these pa-
tients may take more time to educate, we do not know
whether it is feasible to overcome the greater level of
challenges faced by dialysis providers in educating them
about transplant.
Upon completion of this investigation, we will have
assessed the effectiveness of a program that delivers
health education directly to patients’ homes in small, di-
gestible increments. Additionally, we will be able to ex-
plore the effectiveness of text messaging as a means of
delivering health education to patients within a low-
income population. Hopefully, these methods prove to
be effective at alleviating staff burden within dialysis
centers, educating patients in an engaging fashion, and
providing a potentially cost-effective strategy for dissem-
inating transplant education. Furthermore, through this
trial, we will have developed an education program that
could be delivered directly to patients through a health-
care organization, health insurance company, or other
community partners—all organizations that have contin-
ued access to patients as a result of the managed care
they provide. Next steps will include examining the
effectiveness of ETH educational approaches with His-
panics, the most rapidly increasing portion of the ESRD
population in the United States [1] who may face par-
ticular challenges around pursuing transplant [63, 64]
and assessing the generalizability of these findings in
other regions of the country.
Abbreviations
ESRD: End-stage renal disease; CKD: Chronic Kidney Disease; LDKT: Living
donor kidney transplant; DDKT: Deceased donor kidney transplant;
ET: Explore Transplant; ETH: Explore Transplant at Home; ETH-PG: Explore
Transplant at Home Patient-Guided Condition; ETH-EG: Explore Transplant
at Home Educator-Guided Condition; TTM: Transtheoretical Model of
Behavioral Change; RCT: Randomized controlled trial; SES: Socioeconomic
status; MoKP: Missouri Kidney Program; REDCap: Research Electronic Data
Capture; MRM: Multilevel Random Effects Model.
Competing interests
The authors have no competing interests relevant to this manuscript.
Authors’ contributions
All authors read and approved the final manuscript, and all authors made
intellectual contributions to the design of the trial. ADW, AMM, and JDP
prepared the manuscript. CJG, JLT, LJP, and PAL revised the manuscript.
Acknowledgements
We would like to acknowledge Cate Rudder and the Kilgore’s Pharmacy staff
for their support and exceptional patient recruitment efforts. Additionally, we
would like to acknowledge Katherine M. Buckner and Marisa S. Torres for
their assistance with manuscript formatting and the development of our
electronic reference library.
Funding
This research was supported by the Human Resources and Services
Administration [4R39OT26843-01-02] and by the UCLA Clinical and
Translational Science Institute grant [UL1TR000124].
Author details
1Division of Nephrology, David Geffen School of Medicine at University of
California, Los Angeles, 10940 Wilshire Blvd, Suite 1223, Los Angeles, CA
90024, USA. 2Division of General Medical Sciences, Washington University
School of Medicine, Campus Box 8005, 660 S. Euclid Ave., St. Louis, MO
63110, USA. 3Missouri Kidney Program, University of Missouri, Columbia, AP
Green Building, Suite 111, 201 Business Loop-70 W, Columbia, MO 65211,
USA.
Received: 29 May 2015 Accepted: 7 August 2015
References
1. United States Renal Data System. 2014 Annual Data Report: Epidemiology
of Kidney Disease in the United States. Bethesda, MD: National Institutes of
Health, National Institute of Diabetes and Digestive and Kidney Diseases;
2014.
2. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term
dialysis on the subsequent survival of renal transplants from living donors.
N Engl J Med. 2001;344(10):726–31.
3. Neipp M, Karavul B, Jackobs S, Meyer zu Vilsendorf A, Richter N, Becker T,
et al. Quality of life in adult transplant recipients more than 15 years after
kidney transplantation. Transplantation. 2006;81(12):1640–4.
4. Centers for Medicare & Medicaid Services (CMS), Department of Health
and Human Services. Medicare and Medicaid programs; conditions for
coverage for end-stage renal disease facilities. Final rule. Fed Regist.
2008;73(73):20369–484.
5. Bleyer A: Prevention of sudden cardiac death in dialysis patients: A
nephrologist's perspective. Dialysis & Transplantation 2008;37(4):124–129.
6. Brunkhorst R, Lufft V, Dannenberg B, Kliem V, Tusch G, Pichlmayr R.
Improved survival in patients with type 1 diabetes mellitus after renal
transplantation compared with hemodialysis: a case–control study.
Transplantation. 2003;76(1):115–9.
7. Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, et al.
Effect of waiting time on renal transplant outcome. Kidney Int.
2000;58(3):1311–7.
8. Waterman AD, Peipert JD, Hyland SS, McCabe MS, Schenk EA, Liu J.
Modifiable patient characteristics and racial disparities in evaluation
completion and living donor transplant. Clin J Am Soc Nephrol.
2013;8:995–1002.
Waterman et al. BMC Nephrology  (2015) 16:150 Page 9 of 11
9. Kutner NG, Zhang R, Huang Y, Johansen KL. Impact of race on predialysis
discussions and kidney transplant preemptive wait-listing. Am J Nephrol.
2012;35(4):305–11.
10. Johns TS, Estrella MM, Crews DC, Appel LJ, Anderson CA, Ephraim PL, et al.
Neighborhood socioeconomic status, race, and mortality in young adult
dialysis patients. J Am Soc Nephrol. 2014;25(11):2649–57.
11. Hardinger KL, Hutcherson T, Preston D, Murillo D. Influence of pill burden and
drug cost on renal function after transplantation. Pharmacotherapy.
2012;32(5):427–32.
12. McGee J, Jackson NR, Slakey DP. Disability and kidney transplantation in the
United States. Clin Transpl. 2012;26(3):377–81.
13. Chenitz KB, Fernando M, Shea JA. In-center hemodialysis attendance:
patient perceptions of risks, barriers, and recommendations. Hemodial Int.
2014;18(2):364–73.
14. Chan KE, Thadhani RI, Maddux FW. Adherence barriers to chronic dialysis in
the United States. J Am Soc Nephrol. 2014;25(11):2642–8.
15. Harley KT, Streja E, Rhee CM, Molnar MZ, Kovesdy CP, Amin AN, et al.
Nephrologist caseload and hemodialysis patient survival in an urban cohort.
J Am Soc Nephrol. 2013;24:1–10.
16. Balhara KS, Kucirka LM, Jaar BG, Segev DL. Disparities in provision of
transplant education by profit status of the dialysis center. Am J Transplant.
2012;12(11):3104–10.
17. Patzer RE, Plantinga L, Krisher J, Pastan SO. Dialysis facility and network
factors associated with low kidney transplantation rates among United
States dialysis facilities. Am J Transplant. 2014;14(7):1562–72.
18. Waterman AD, Goalby C, Hyland SS, McCabe M, Dinkel KM (2012) Transplant
Education Practices and Attitudes in Dialysis Centers: Dialysis Leadership
Weighs In. J Nephrol Therapeutic S4:007. doi:10.4172/2161-0959.S4-007.
19. Waterman A, Hyland S, Stanley SL, Barrett AC, Millinger R: Improving
education increases dialysis patients' pursuit of transplant: Explore
Transplant RCT findings. In: American Transplant Congress: May 30-June 3
2009; Boston, MA: American journal of transplantation; 2009: 360
20. Waterman AD, Goalby C, Hyland S: Dialysis providers ability to educate
patients about transplant: good education partners? In: American Transplant
Congress: May 30-June 3 2009; Boston, MA; 2009
21. LaPointe RD, Hays R, Baliga P, Cohen DJ, Cooper M, Danovitch GM, et al.
Consensus conference on best practices in live kidney donation:
recommendations to optimize education, access, and care. Am J Transplant.
2015;15(4):912–22.
22. Boulware LE, Hill-Briggs F, Kraus ES, Melancon JK, Falcone B, Ephraim PL, et
al. Effectiveness of educational and social worker interventions to activate
patients' discussion and pursuit of preemptive living donor kidney
transplantation: a randomized controlled trial. Am J Kidney Dis.
2012;61(3):476–86.
23. Schmittdiel JA, Brown SD, Neugebauer R, Adams SR, Adams AS, Wiley
D, et al. Health-plan and employer-based wellness programs to reduce
diabetes risk: the Kaiser permanente Northern California NEXT-D Study.
Prev Chronic Dis. 2013;10:E15.
24. Rodrigue JR, Paek MJ, Egbuna O, Waterman AD, Schold JD, Pavlakis M,
et al. Making house calls increases living donor inquiries and
evaluations for blacks on the kidney transplant waiting list.
Transplantation. 2014;98(9):979–86.
25. Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in
disease prevention and management. Epidemiol Rev. 2010;32(1):56–69.
26. Lim MS, Hocking JS, Hellard ME, Aitken CK. SMS STI: a review of the uses of
mobile phone text messaging in sexual health. Int J STD AIDS.
2008;19(5):287–90.
27. Chen RA, Scott S, Mattern WD, Mohini R, Nissenson AR. The case for disease
management in chronic kidney disease. DM. 2006;9(2):86–92.
28. NASW Standards for Social Work Case Management [http://
www.socialworkers.org/practice/standards/sw_case_mgmt.asp]
29. Standards of practice for case management [http://www.cmsa.org/]
30. Glanz K, Bishop DB. The role of behavioral science theory in
development and implementation of public health interventions. Annu
Rev Public Health. 2010;31:399–418.
31. Prochaska JO, Redding CA, Evers KE. The transtheoretical model and
stages of change. In: Glanz K, Rimer B, Lewis F, editors. Health Behavior
and Health Education. 3rd ed. San Francisco, CA: Jossey-Bass;
2002. p. 99–120.
32. Prochaska JO. Decision making in the transtheoretical model of behavior
change. Med Decis Making. 2008;28(6):845–9.
33. Prochaska JO, DiClemente CC. Stages and processes of self-change of
smoking: toward an integrative model of change. J Consult Clin
Psychol. 1983;51(3):390–5.
34. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change:
applications to addictive behaviors. Am Psychol. 1992;47(9):1102–14.
35. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS. Standardized,
individualized, interactive, and personalized self-help programs for smoking
cessation. Health Psychol. 1993;12(5):399–405.
36. Prochaska JO, Norcross JC. Stages of change. Psychother Theory Res Pract
Train. 2001;38(4):443–8.
37. Prochaska JO, Velicer WF, Redding C, Rossi JS, Goldstein M, DePue J,
et al. Stage-based expert systems to guide a population of primary
care patients to quit smoking, eat healthier, prevent skin cancer, and
receive regular mammograms. Prev Med. 2005;41(2):406–16.
38. Robbins ML, Levesque DA, Redding CA, Johnson JL, Prochaska JO, Rohr MS, et
al. Assessing family members’ motivational readiness and decision making for
consenting to cadaveric organ donation. J Health Psychol. 2001;6(5):523–35.
39. Hall KL, Robbins ML, Paiva A, Knott JE, Harris L, Mattice B. Donation
intentions among African American college students: decisional balance
and self-efficacy measures. J Behav Med. 2007;30(6):483–95.
40. Waterman AD, Brown J, Witten B, Goodnight V, Mallery C, Schenk E,
Goalby C, Frazier L, Peace L, Hyland SS: Preemptive Transplant Knowledge
and Decision-Making: Impact of a Community Chronic Kidney Disease
Education Class. In: National Kidney Foundation Spring Clinical Meetings.
National Harbor, MD; 2012
41. United States Census Bureau: Text-Messaging Soars. In: Census Bureau
Releases 2010 Statistical Abstract Depicting the State of Our Nation. 2009.
42. United States Census Bureau: Homes With Cell Phones Nearly Double in
First Half of Decade. 2014. Washington, DC: United States Census Bureau;
2009..
43. Vervloet M, van Dijk L, Santen-Reestman J, van Vlijmen B, van Wingerden
P, Bouvy ML, et al. SMS reminders improve adherence to oral medication
in type 2 diabetes patients who are real time electronically monitored. J
Med Inform. 2012;81(9):594–604.
44. Leong KC, Chen WS, Leong KW, Mastura I, Mimi O, Sheikh MA, et al.
The use of text messaging to improve attendance in primary care: a
randomized controlled trial. Fam Pract. 2006;23(6):699–705.
45. Siebens J: Extended Measures of Well-Being: Living Conditions in the United
States: 2011. Washington DC: United States Census Bureau; 2013. 70–136.
46. Smith A: Americans and Their Cell Phones. In. Washington, DC: Pew Internet
and American Life Project; 2011:1–19
47. SongWhale [http://www.songwhale.com/]
48. Hekkers V. Insurance reimbursement. Case Manager. 2005;16(3):34–5.
49. O’Connor AM. Validation of a decisional conflict scale. Med Decis Making.
1995;15(1):25–30.
50. Waterman A, Robbins M, Paiva A, Hyland SS. Kidney patients' intention to
receive a deceased donor transplant: Development of stage of change,
decisional balance, and self-efficacy measures. J Health Psychol.
2010;15(3):436–45.
51. Waterman AD, Robbins ML, Paiva AL, Peipert JD, Davis LA, Hyland SS, et
al. Measuring kidney patients’ motivation to pursue living donor kidney
transplant: development of stage of change, decisional balance and
self-efficacy measures. J Health Psychol. 2015;20(2):210–21.
52. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life.
Ann Intern Med. 1993;118(8):622–9.
53. LaVeist TA, Isaac LA, Williams KP. Mistrust of health care organizations is
associated with underutilization of health services. Health Serv Res.
2009;44(6):2093–105.
54. Boulware LE, Ratner LE, Cooper LA, Sosa JA, LaVeist TA, Powe NR.
Understanding disparities in donor behavior: race and gender differences
in willingness to donate blood and cadaveric organs. Med Care.
2002;40(2):85–95.
55. National Institutes of Health Centers for Population Health and Health
Disparities: Core Measures Database. Edited by Centers for Population
Health and Health Disparities. Bethesda, MD 2012.
56. Gehlert S: University of Chicago CIHDR Women’s Community Study
Questionnaire. Center for Interdisciplinary Health Disparities Research,
University of Chicago 2008.
57. Chew LD, Griffin JM, Partin MR, Noorbaloochi S, Grill JP, Snyder A, et al.
Validation of screening questions for limited health literacy in a large VA
outpatient population. J Gen Intern Med. 2008;23(5):561–6.
Waterman et al. BMC Nephrology  (2015) 16:150 Page 10 of 11
58. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research
electronic data capture (REDCap)–a metadata-driven methodology and
workflow process for providing translational research informatics support.
J Biomed Inform. 2009;42(2):377–81.
59. Murray DM. Design and Analysis of Group-Randomized Control Trials.
Oxford: Oxford University Press; 1998.
60. Rubin DB. Multiple imputation for nonresponse in surveys. New York: John
Wiley & Sons, Inc.; 1987.
61. Nordio M, Limido A, Maggiore U, Nichelatti M, Postorino M, Quintaliani G.
Survival in patients treated by long-term dialysis compared with the general
population. Am J Kidney Dis. 2012;59(6):819–28.
62. Sullivan C, Leon JB, Sayre SS, Marbury M, Ivers M, Pencak JA, et al. Impact of
navigators on completion of steps in the kidney transplant process: a
randomized, controlled trial. Clin J Am Soc Nephrol. 2012;7(10):1639–45.
63. Gordon EJ, Mullee JO, Ramirez DI, MacLean J, Olivero M, Feinglass J, et al.
Hispanic/Latino concerns about living kidney donation: a focus group study.
Prog Transplant. 2014;24(2):152–62.
64. Gordon EJ, Reddy E, Gil S, Feinglass J, Rodde J, Abecassis MM, et al.
Culturally competent transplant program improves Hispanics’ knowledge
and attitudes about live kidney donation and transplant. Prog Transplant.
2014;24:56–68.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Waterman et al. BMC Nephrology  (2015) 16:150 Page 11 of 11
